Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccine for Multiple Common Warts
NCT05326152Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Hepatitis B vaccine in common warts, sponsored by Zagazig University. Started Nov 2020; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
common warts
Beyond the preview
Go deeper on NCT05326152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326152.